Research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/members

Cancer Moonshot℠ Blue Ribbon Panel Members

The Blue Ribbon Panel is composed of leading experts from a broad range of scientific areas, including biology, immunology, genomics, diagnostics, bioinformatics, and cancer prevention and treatment. Members also include investigators with expertise in clinical trials and cancer health disparities, as well as representatives of cancer advocacy groups and pharmaceutical and biotechnology companies.

The members of the Blue Ribbon Panel are:

Tyler Jacks, Ph.D. (Co-Chair)Exit Disclaimer

Chair, National Cancer Advisory Board

Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Elizabeth Jaffee, M.D. (Co-Chair)Exit Disclaimer

Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

Dinah Singer, Ph.D. (Co-Chair and Designated Federal Official)

Acting Deputy Director, National Cancer Institute

Director, Division of Cancer Biology, National Cancer Institute

Peter Adamson, M.D.Exit Disclaimer

Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia

James Allison, Ph.D.Exit Disclaimer

Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center

David Arons, J.D.Exit Disclaimer

Chief Executive Officer, National Brain Tumor Society

Mary Beckerle, Ph.D.Exit Disclaimer

Chief Executive Officer and Director, Huntsman Cancer Institute, University of Utah

Mitch Berger, M.D.Exit Disclaimer

Professor and Chair, Department of Neurological Surgery, University of California, San Francisco

Jeff Bluestone, Ph.D.Exit Disclaimer

A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology, University of California, San Francisco

Chi Van Dang, M.D., Ph.D.Exit Disclaimer

Scientific Director, Ludwig Cancer Research

Mikael Dolsten, M.D., Ph.D.Exit Disclaimer

President, Pfizer Worldwide Research and Development

Executive Vice President, Pfizer, Inc.

James Downing, M.D.Exit Disclaimer

President and Chief Executive Officer, St. Jude Children’s Research Hospital

Levi Garraway, M.D., Ph.D.

Senior Vice President, Global Development and Medical Affairs, Lilly Oncology, Eli Lilly and Company

Gad Getz, Ph.D.Exit Disclaimer

Director of Cancer Genome Computational Analysis Group and Institute Member, Broad Institute of MIT and Harvard

Director, Bioinformatics Program, Massachusetts General Hospital Cancer Center and Department of Pathology

Associate Professor of Pathology, Harvard Medical School

Paul C. Zamecnik Chair in Oncology, MGH Cancer Center

Laurie Glimcher, M.D.Exit Disclaimer

Professor of Medicine and Stephen and Suzanne Weiss Dean, Weill Cornell Medical College

Incoming President and Chief Executive Officer, Dana-Farber Cancer Institute

Lifang Hou, M.D., Ph.D.Exit Disclaimer

Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine

Neal Kassell, M.D.Exit Disclaimer

Chairman, Focused Ultrasound Foundation

Professor of Neurosurgery, University of Virginia

María Elena Martínez, Ph.D.Exit Disclaimer

Sam M. Walton Endowed Chair for Cancer Research, Professor of Family Medicine and Public Health, and Co-director of the Reducing :Cancer Disparities Program, UC San Diego Moores Cancer Center

Deborah Mayer, Ph.D., R.N.Exit Disclaimer

Professor of Adult and Geriatric Health, University of North Carolina School of Nursing

Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center

Edith Mitchell, M.D., F.A.C.PExit Disclaimer

Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University

Augusto Ochoa, M.D.Exit Disclaimer

Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University

Jennifer Pietenpol, Ph.D.Exit Disclaimer

Benjamin F. Byrd, Jr. Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center

Angel Pizarro, M.S.E.Exit Disclaimer

Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing

Barbara Rimer, Dr.P.H.Exit Disclaimer

Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health

Charles Sawyers, M.D.Exit Disclaimer

Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Investigator, Howard Hughes Medical Institute

Ellen Sigal, Ph.D.Exit Disclaimer

Founder and Chair, Friends of Cancer Research

Patrick Soon-Shiong, M.D., FRCS (C), FACSExit Disclaimer

Founder, Chair, and CEO, NantWorks LLC

Wai-Kwan Alfred Yung, M.D.Exit Disclaimer

Professor of Neuro-Oncology and Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center

Ex Officio members of the Blue Ribbon Panel are:

David Atkins, M.D., M.P.H.

Acting Chief Research and Development Officer, Department of Veterans Affairs

Robert Califf, M.D.

Commissioner, U.S. Food and Drug Administration

Karen Guice, M.D., M.P.P.

Acting Assistant Secretary of Defense for Health Affairs, Department of Defense

Jason Paragas, Ph.D.Exit Disclaimer

Director of Innovation, Lawrence Livermore National Laboratory

Lawrence Tabak, D.D.S., Ph.D.

Principal Deputy Director, National Institutes of Health